SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193805-24-000595
Filing Date
2024-05-06
Accepted
2024-05-06 06:00:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 prec14a11882nvax_05032024.htm PREC14A 249494
2 GRAPHIC image_001.jpg GRAPHIC 6481
3 GRAPHIC image_002.jpg GRAPHIC 6481
4 GRAPHIC image_003.jpg GRAPHIC 19811
5 GRAPHIC image_004.jpg GRAPHIC 11222
6 GRAPHIC image_005.jpg GRAPHIC 6481
  Complete submission text file 0001193805-24-000595.txt   321278
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 000-26770 | Film No.: 24915377
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2301 SUGAR BUSH RD SUITE 510 RALEIGH NC 27612
Business Address 2301 SUGAR BUSH RD SUITE 510 RALEIGH NC 27612 919 719 6360
SHAH CAPITAL MANAGEMENT (Filed by) CIK: 0001383838 (see all company filings)

IRS No.: 201804775 | State of Incorp.: NC | Fiscal Year End: 1231
Type: PREC14A